These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1181670)

  • 1. The effect of phenformin-HCl on patients with diabetes mellitus, studied under strict balance conditions.
    Geldermans CA; Terpstra J; Krans HM
    Diabetologia; 1975 Oct; 11(5):475-82. PubMed ID: 1181670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenformin effect on body weight, lipids, and glucose regulation.
    Alterman SL; Lopez-Gomez AA
    Ann N Y Acad Sci; 1968 Mar; 148(3):884-91. PubMed ID: 4872312
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of phenformin on amino acid-induced insulin secretion in diabetics.
    Czyzyk A; Lawecki J; Rogala H; Malczewski B; Kowalski H
    Diabetologia; 1975 Apr; 11(2):125-8. PubMed ID: 1149946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phenformin on glucose-insulin interrelationships.
    Stout RW; Brunzell JD; Bierman EL; Porte D
    Diabetes; 1974 Jul; 23(7):624-30. PubMed ID: 4841569
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenformin effect on body weight, lipids and glucose regulation.
    Alterman SL
    Pol Arch Med Wewn; 1969; 42(3):291-7. PubMed ID: 5790046
    [No Abstract]   [Full Text] [Related]  

  • 6. LIMITATIONS IN THE USE OF ORAL HYPOGLYCEMIC AGENTS IN JUVENILE PATIENTS WITH DIABETES.
    KAYE R; DAVIDSON MH
    J Pediatr; 1965 May; 66():844-56. PubMed ID: 14279844
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of phenformin hydrochloride on serum cholesterol and triglyceride levels of the stable adult diabetic.
    Schwartz MJ; Mirsky S; Schaefer LE
    Metabolism; 1966 Sep; 15(9):808-22. PubMed ID: 5929037
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenformin therapy of chemical diabetes.
    Danowski TS; Sunder JH; Stephan T; Nolan S; Ohlsen PM; Ahmad U; Vidalon C; Wingert JP
    J Clin Pharmacol; 1974; 14(11-12):638-50. PubMed ID: 4140199
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes mellitus and obesity: phenformin hydrochloride as a research tool. Concluding remarks.
    Danowski TS
    Ann N Y Acad Sci; 1968 Mar; 148(3):958-62. PubMed ID: 5241487
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of jambolan seed treatment on blood sugar, lipids and urea in streptozotocin induced diabetes in rabbits.
    Kedar P; Chakrabarti CH
    Indian J Physiol Pharmacol; 1983; 27(2):135-40. PubMed ID: 6885126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of phenethylbiguanide (phenformin) in man. III. interrelationship between ethanol and phenethylibiguanide (PBG) in normal and diabetic subjects.
    Wajchenberg BL; Halpern A; Leme CE; Lerário AC; Silveria AA; Fioratti PA; Cesar FP
    Metabolism; 1976 Sep; 25(9):957-71. PubMed ID: 958002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus.
    Butterfield WJ
    Ann N Y Acad Sci; 1968 Mar; 148(3):724-33. PubMed ID: 5242146
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
    Beringer A
    Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
    [No Abstract]   [Full Text] [Related]  

  • 14. PHENFORMIN, SERUM LIPIDS AND DIABETES MELLITUS.
    SCHWARTZ MJ; MIRSKY S; SCHAEFER LE
    Lancet; 1965 May; 1(7392):959. PubMed ID: 14275725
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes mellitus and obesity: phenformin hydrochloride as a research tool.
    Danowski TS
    Metabolism; 1967 Sep; 16(9):865-9. PubMed ID: 4860366
    [No Abstract]   [Full Text] [Related]  

  • 16. [Initial results in the treatment of diabetes mellitus with an association of glibenclamide and phenformin].
    Carta Q; Pugliese F
    Minerva Med; 1974 Jan; 65(1):27-57. PubMed ID: 4214410
    [No Abstract]   [Full Text] [Related]  

  • 17. RELATIONSHIP BETWEEN INTRAVENOUS GLUCOSE TOLERANCE AND THE FASTING BLOOD GLUCOSE LEVEL IN HEALTHY AND IN DIABETIC SUBJECTS.
    MOORHOUSE JA; GRAHAME GR; ROSEN NJ
    J Clin Endocrinol Metab; 1964 Feb; 24():145-59. PubMed ID: 14123838
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of hypoglycemic agents on blood lipids and body weight in ketoacidosis-resistant diabetics.
    Gershberg H; Javier Z; Hulse M; Hecht A
    Ann N Y Acad Sci; 1968 Mar; 148(3):914-24. PubMed ID: 4968572
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.
    Henry RR; Wiest-Kent TA; Scheaffer L; Kolterman OG; Olefsky JM
    Diabetes; 1986 Feb; 35(2):155-64. PubMed ID: 3510922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics.
    Nattrass M; Todd PG; Hinks L; Lloyd B; Alberti KG
    Diabetologia; 1977 Apr; 13(2):145-52. PubMed ID: 404205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.